| Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection M Ali, RK Pandey, N Khatoon, A Narula, A Mishra, VK Prajapati Scientific reports 7 (1), 9232, 2017 | 367 | 2017 |
| Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use S Sundar, A Singh, M Rai, VK Prajapati, AK Singh, B Ostyn, M Boelaert, ... Clinical infectious diseases 55 (4), 543-550, 2012 | 352 | 2012 |
| Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach N Khatoon, RK Pandey, VK Prajapati Scientific reports 7 (1), 8285, 2017 | 346 | 2017 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 258 | 2024 |
| Novel Immunoinformatics Approaches to Design Multi-epitope Subunit Vaccine for Malaria by Investigating Anopheles Salivary Protein RK Pandey, TK Bhatt, VK Prajapati Scientific reports 8 (1), 1125, 2018 | 231 | 2018 |
| Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent H Imamura, T Downing, F Van den Broeck, MJ Sanders, S Rijal, S Sundar, ... Elife 5, e12613, 2016 | 178 | 2016 |
| Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes VK Prajapati, K Awasthi, S Gautam, TP Yadav, M Rai, ON Srivastava, ... Journal of antimicrobial chemotherapy 66 (4), 874-879, 2011 | 174 | 2011 |
| Molecular and immunological toxic effects of nanoparticles RK Pandey, VK Prajapati International journal of biological macromolecules 107, 1278-1293, 2018 | 141 | 2018 |
| Immunoinformatics approaches to design a novel multi-epitope subunit vaccine against HIV infection RK Pandey, R Ojha, VS Aathmanathan, M Krishnan, VK Prajapati Vaccine 36 (17), 2262-2272, 2018 | 129 | 2018 |
| Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis V Bhandari, A Kulshrestha, DK Deep, O Stark, VK Prajapati, V Ramesh, ... PLoS neglected tropical diseases 6 (5), e1657, 2012 | 124 | 2012 |
| Circulating MicroRNAs: potential and emerging biomarkers for diagnosis of human infectious diseases P Verma, RK Pandey, P Prajapati, VK Prajapati Frontiers in microbiology 7, 1274, 2016 | 118 | 2016 |
| Racial disparities in prostate cancer: a molecular perspective A Bhardwaj, SK Srivastava, MA Khan, VK Prajapati, S Singh, JE Carter, ... Frontiers in bioscience (Landmark edition) 22, 772, 2017 | 110 | 2017 |
| Differential expression of miRNA regulates T cell differentiation and plasticity during visceral leishmaniasis infection RK Pandey, S Sundar, VK Prajapati Frontiers in microbiology 7, 206, 2016 | 100 | 2016 |
| An oral formulation of amphotericin B attached to functionalized carbon nanotubes is an effective treatment for experimental visceral leishmaniasis VK Prajapati, K Awasthi, TP Yadav, M Rai, ON Srivastava, S Sundar Journal of Infectious Diseases 205 (2), 333-336, 2012 | 100 | 2012 |
| Designing B‐and T‐cell multi‐epitope based subunit vaccine using immunoinformatics approach to control Zika virus infection R Kumar Pandey, R Ojha, A Mishra, V Kumar Prajapati Journal of cellular biochemistry 119 (9), 7631-7642, 2018 | 99 | 2018 |
| Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells R Mukhopadhyay, S Mukherjee, B Mukherjee, K Naskar, D Mondal, ... International journal for parasitology 41 (13-14), 1311-1321, 2011 | 98 | 2011 |
| High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment B Naik, N Gupta, R Ojha, S Singh, VK Prajapati, D Prusty International Journal of Biological Macromolecules 160, 1-17, 2020 | 96 | 2020 |
| Antileishmanial activity of nano-amphotericin B deoxycholate KD Manandhar, TP Yadav, VK Prajapati, S Kumar, M Rai, A Dube, ... Journal of Antimicrobial Chemotherapy 62 (2), 376-380, 2008 | 96 | 2008 |
| Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product … BK Kumar, n Faheem, KVGC Sekhar, R Ojha, VK Prajapati, A Pai, ... Journal of Biomolecular Structure and Dynamics 40 (3), 1363-1386, 2022 | 87 | 2022 |
| Drug targeting to infectious diseases by nanoparticles surface functionalized with special biomolecules S Sundar, V Kumar Prajapati Current medicinal chemistry 19 (19), 3196-3202, 2012 | 83 | 2012 |
Rajan Kumar Pandey (Ph.D.)Karolinska InstituteVerified email at ki.se
